Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 301–400 of 935
Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1
Dufour, C., Claudel, A., Joubarne, N., Mérindol, N., Maisonnet, T., Masroori, N., Plourde, M. B., & Berthoux, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191709 · Cited by 34
Duo, T., Liu, X., Mo, D., Bian, Y., Cai, S., Wang, M., Li, R., Zhu, Q., Tong, X., Liang, Z., et al. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00930-4 · Cited by 31
“…to create site specific changes to the genomes of livestock to improve important economic traits in a single generation [28], but the HDR dependent point mutation induced by CRISPR-Cas9 often induces additional (bystanding) indels, which may confound the genetic effects of target mutations [29].”
BackgroundEngineered CRISPR Systems for Next Generation Gene Therapies
Pineda, M., Moghadam, F., Ebrahimkhani, M. R., & Kiani, S. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00011 · Cited by 32
Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue
Mannhardt, I., Warncke, C., Trieu, H. K., Müller, J. W., & Eschenhagen, T. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2755 · Cited by 31
“CRISPR/Cas9 genome editing technology (Paquet et al., 2016) allows the establishment of precise molecular cause–effect relationships in a human cardiomyocyte context (Mosqueira et al.”
BackgroundOrthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
Bolukbasi, M. F., Liu, P., Luk, K., Kwok, S. F., Gupta, A., Amrani, N., Sontheimer, E. J., Zhu, L. J., & Wolfe, S. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07310-x · Cited by 31
Genome editing of human pancreatic beta cell models: problems, possibilities and outlook
Balboa, D., Prasad, R. B., Groop, L., & Otonkoski, T. (2019) · Diabetologia · doi:10.1007/s00125-019-4908-z · Cited by 34
“An interesting advantage of base editing is its high efficiency in quiescent cells [38], in contrast to the inefficiency of HDR in non-dividing cells.”
BackgroundInfluentialMS‐based strategies for identification of protein SUMOylation modification
Sheng, Z., Wang, X., Ma, Y., Zhang, D., Yang, Y., Zhang, P., Zhu, H., Xu, N., & Liang, S. (2019) · Electrophoresis · doi:10.1002/elps.201900100 · Cited by 30
Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease
Chen, J., Chen, J.-S., Li, S., Zhang, F., Deng, J., Zeng, L., & Tan, J. (2023) · Aging and Disease · doi:10.14336/ad.2023.0308 · Cited by 59
“APP mutations directly affect the production of Aβ, and increased expression or excessive endocytosis of APP protein accelerates the pathological process of AD [17].”
BackgroundDefects in homologous recombination repair behind the human diseases: FA and HBOC
Katsuki, Y., & Takata, M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0221 · Cited by 32
Lish, A. M., Ashour, N., Pearse, R. V., Galle, P. C., Orme, G. A., Heuer, S. E., Benoit, C. R., Alexander, K. D., Grogan, E. F. L., Terzioglu, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115777 · Cited by 36
“36,37 The lines used in each subsequent figure are detailed in Table S1.”
Highly Efficient CRISPR‐Cas9‐Mediated Genome Editing in Human Pluripotent Stem Cells
Maguire, J. A., Cardenas‐Diaz, F. L., Gadue, P. J., & French, D. L. (2018) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.64 · Cited by 30
Yang, G., Zhou, C., Wang, R., Huang, S., Yu, W., Yang, X., Liu, Y., Li, J., Lu, Z., Ying, W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.046 · Cited by 31
Basic and Preclinical Research for Personalized Medicine
Lattanzi, W., Ripoli, C., Greco, V., Barba, M., Iavarone, F., Minucci, A., Urbani, A., Grassi, C., & Parolini, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050354 · Cited by 32
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Chen, X., Guo, R., Zhao, C., Xu, J., Song, H., Yu, H., Pilarsky, C. P., Nainu, F., Li, J., Zhou, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.939090 · Cited by 34
“amyloid precursor protein and derived cortical neurons (Paquet et al., 2016).”
BackgroundNeurodegenerative Lysosomal Storage Disorders: TPC2 Comes to the Rescue!
Castro, S. P., Kudrina, V., Jaślan, D., Böck, J., Rosato, A. S., & Grimm, C. M. (2022) · Cells · doi:10.3390/cells11182807 · Cited by 36
“From these, cortical neurons were derived following established protocols [31,32].”
MethodHuman TMEFF1 is a restriction factor for herpes simplex virus in the brain
Chan, Y.-H., Liu, Z., Bastard, P., Khobrekar, N. V., Hutchison, K. M., Yamazaki, Y., Fan, Q., Matuozzo, D., Harschnitz, O., Kerrouche, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07745-x · Cited by 33
“Gene-editing experiments were performed as previously described 36 .”
Acosta, S., Fiore, L., Carota, I. A., & Oliver, G. C. (2018) · genesis · doi:10.1002/dvg.23212 · Cited by 30
“Recently, major efforts aimed to improve the efficiency of the generation of bi-allelic targeted mutations have been reported; however, the reported success rates remain very low even in non ESC/iPSC cells (Paquet et al., 2016; Takayama et al., 2017).”
BackgroundA human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents
He, S., Zambelli, V. O., Sinharoy, P., Brabenec, L., Bian, Y., Rwere, F., Hell, R. C. R., Neto, B. S., Hung, B., Yu, X., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci163735 · Cited by 34
“The donor single-stranded oligodeoxynucleotide (ssOD) contains a missense mutation for K710N (red base) and 2 silent mutations (green bases) in the gRNA protospacer adjacent motif (PAM) site (purple bases) to block the PAM sequence and thereby prevent recutting of the corrected mutated alleles by gRNA-Cas9 (18) (Figur…”
BackgroundVerstraelen, P., Detrez, J. R., Verschuuren, M., Kuijlaars, J., Nuydens, R., Timmermans, J., & Vos, W. H. D. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00173 · Cited by 30
“Though current reprogramming protocols are tedious and time-consuming as compared to cultivating mouse primary neurons, they can even be derived from patients with sporadic forms of the disease (Armijo et al., 2017) and can be combined with gene editing approaches (Paquet et al., 2016).”
BackgroundIshida, K., Xu, H., Sasakawa, N., Lung, M. S. Y., Kudryashev, J. A., Gee, P., & Hotta, A. (2018) · Scientific Reports · doi:10.1038/s41598-017-18568-4 · Cited by 28
“7% “CORRECT” method (13) iPSC PSEN SpCas9 electroporation as plasmid DNA 1.”
MethodProgrammable Single and Multiplex Base-Editing in Bombyx mori Using RNA-Guided Cytidine Deaminases
Li, Y., Ma, S., Sun, L., Zhang, T., Chang, J., Lü, W., Chen, X., Liu, Y., Wang, X., Shi, R., et al. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200134 · Cited by 30
Evolution of CRISPR towards accurate and efficient mammal genome engineering
Ryu, S.-M., Hur, J. W., & Kim, K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.8.149 · Cited by 29
“These mutations prevented re-cleavage of inserted sequences by CRISPR/Cas9 and increased precise knock-in efficiency (40).”
BackgroundChristie, K. A., Robertson, L. J., Conway, C., Blighe, K., DeDionisio, L., Chao-Shern, C., Kowalczyk, A. M., Marshall, J., Turnbull, D. M., Nesbit, M. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.05.002 · Cited by 33
CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B
Pöhler, M., Guttmann, S., Nadzemova, O., Lenders, M., Brand, E., Zibert, A., Schmidt, H., & Sandfort, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239411 · Cited by 35
“To prevent a re-editing by the highly active Cas9 nuclease, the introduction of blocking mutations in ssODNs located within the PAM sequence or guide RNA target have minimized undesirable re-editing during gene editing [30].”
BackgroundDavaapil, H., Shetty, D. K., & Sinha, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.550504 · Cited by 28
Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs
Guo, H., Liu, L., Nishiga, M., Cong, L., & Wu, J. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.009 · Cited by 33
Gu, X. G., Hu, X., Wang, D., Xu, Z., Wang, F., Li, D., Li, G., Yang, H., Li, H., Zuo, E., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00624-y · Cited by 28
Membrane lipid remodeling modulates γ-secretase processivity
Dawkins, E., Derks, R. J. E., Schifferer, M., Trambauer, J., Winkler, E., Simons, M., Paquet, D., Giera, M. A., Kamp, F., & Steiner, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103027 · Cited by 32
Self-citationMorio, F., Lombardi, L., Binder, U., Logé, C., Robert, E., Grässle, D., Bodin, M., Lass‐Flörl, C., Butler, G., & Pape, P. L. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz204 · Cited by 29
Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads
Leandro, K., Rufino‐Ramos, D., Breyne, K., Ianni, E. D., Lopes, S., Nobre, R. J., Kleinstiver, B. P., Perdigão, P. R. L., Breakefield, X. O., & de Almeida, L. P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115346 · Cited by 28
CRISPR/Cas therapeutic strategies for autosomal dominant disorders
Caruso, S. M., Quinn, P. M. J., da Costa, B. L., & Tsang, S. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158287 · Cited by 29
Systematic Functional Analysis of PINK1 and PRKN Coding Variants
Broadway, B. J., Boneski, P. K., Bredenberg, J. M., Kolicheski, A., Hou, X., Soto‐Beasley, A. I., Ross, O. A., Springer, W., & Fiesel, F. C. (2022) · Cells · doi:10.3390/cells11152426 · Cited by 28
“For D525N we added an additional silent mutation at the adjacent 5′ triplet (TTA [L] to CTT [L]) with similar codon usage to serve as blocking mutation and prevent re-editing of the WT allele [39] for the generation of heterozygous D525N clones.”
BackgroundLuan, X., Chen, X., Tang, Y., Zhang, J., Gao, X., Ke, H., Lin, Z., & Zhang, X. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.005 · Cited by 29
“PAM-site mutations seem broadly effective, so sgRNA target mutations may have variable effects at different loci.(19) Here, our data demonstrated that the sgRNA with the cut-site mutation (sg1) was more efficient than that with the PAM-site mutation (sg2) (Figures 1B and 1C).”
BackgroundNeuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
Raikwar, S. P., Thangavel, R., Dubova, I., Ahmed, M. E., Selvakumar, G. P., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180422 · Cited by 31
CRISPR/Cas9-Based Genome Editing Toolbox for Arabidopsis thaliana
Miki, D., Zinta, G., Zhang, W., Peng, F., Feng, Z., & Zhu, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0880-7_5 · Cited by 28
Quadruple pegRNA enables programmable and efficient large genomic insertion
Shi, Y.-J., Ding, Z.-Y., Wu, Y., He, Z., Zhang, Y., Zhang, Y.-L., Zhang, Y.-M., Huang, X., Yin, H., & Zhang, Y. (2026) · Nature · doi:10.1038/s41586-026-10395-w · Cited by 27
“Conventional strategies that rely on double-stranded break (DSB)-induced repair pathways, such as non-homologous end joining (NHEJ) and homology-directed repair (HDR), have several limitations 11–13 .”
A coagulation defect arising from heterozygous premature termination of tissue factor
Schulman, S., El-Darzi, E., Florido, M. H. C., Friesen, M., Merrill‐Skoloff, G., Brake, M. A., Schuster, C. R., Lin, L., Westrick, R. J., Cowan, C. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133780 · Cited by 27
“were engineered using a CRISPR/Cas9-based strategy (40) and the”
MethodRecent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
Schreurs, J., Sacchetto, C., Colpaert, R. M. W., Vitiello, L., Rampazzo, A., & Calore, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010985 · Cited by 26
“In fact, it has been shown that the efficiency of editing rapidly decreases with an increase in distance from the cut site [63].”
BackgroundUnbiased evaluation of rapamycin's specificity as an mTOR inhibitor
Artoni, F., Grützmacher, N., & Demetriades, C. (2023) · Aging Cell · doi:10.1111/acel.13888 · Cited by 28
“The Ser2035Thr amino acid substitution was introduced by homology- directed repair (HDR) using a single- stranded DNA oligo as donor template (Paquet et al., 2016).”
MethodCRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
Chacko, L., Chaudhary, A., Singh, B., Dewanjee, S., & Kandimalla, R. J. L. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103652 · Cited by 29
Ge, L., Dong, X., Gong, X., Kang, J., Zhang, Y., & Quan, F. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.043 · Cited by 30
Zebrafish knock-ins swim into the mainstream
Prykhozhij, S. V., & Berman, J. N. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.037515 · Cited by 26
“This is consistent with previous studies (Paquet et al., 2016), and suggests that researchers use longer or symmetric (S) homology arms for engineering knock-ins in which the mutation site is at large distances from the Cas9-induced cut sites.”
The use of CRISPR/Cas associated technologies for cell transplant applications
Cowan, P. J. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000347 · Cited by 25
Hu, M., Cherkaoui, I., Misra, S., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.576632 · Cited by 27
de Vrieze, E., de Bruijn, S. E., Reurink, J., Broekman, S., van de Riet, V., Aben, M., Kremer, H., & van Wijk, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179429 · Cited by 26
“For an efficient introduction of the target variant, the Cas9 cleavage site should be ideally at a distance <10 nt from the target site [8].”
BackgroundXu, H., Kita, Y., Bang, U., Gee, P., & Hotta, A. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100965 · Cited by 26
Perspectives of gene editing for cattle farming in tropical and subtropical regions
Camargo, L. S. A., Saraiva, N. Z., Oliveira, C. S., Carmickle, A. T., de Lemos, D. R., Siqueira, L. G. B., & Denicol, A. C. (2022) · Animal Reproduction · doi:10.1590/1984-3143-ar2022-0108 · Cited by 30
Afanasyeva, T. A. V., Athanasiou, D., Perdigão, P. R. L., Whiting, K., Duijkers, L., Astuti, G., Bennett, J., Garanto, A., van der Spuy, J., Roepman, R., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.05.012 · Cited by 25
“A shorter cut-to-variant distance has been previously shown to improve the probability of homozygous corrections.(15) To estimate the efficiency of editing, we analyzed pooled corrected iPSC clones with the TIDER tool, which showed a high editing efficiency for gRNA1.”
MethodVölgyi, K., González-Gallego, J., Müller, S. A., Beaufort, N., Malik, R., Schifferer, M., Todorov, M. I., Crusius, D., Robinson, S., Schmidt, A., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00598-z · Cited by 28
Self-citationKondrashov, A. V., Hoang, M. D., Smith, J. G. W., Bhagwan, J. R., Duncan, G., Mosqueira, D., Muñoz, M. D. B., Vo, N. T. N., & Denning, C. N. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0268 · Cited by 28
“Analternative toachieving seamless editing by using ssODNs as a template is via a system termed ‘‘ CORRECT ’’ [9]; however, this requirestwo sequential clonal selection/expansion steps.”
Tamai, M., Inukai, T., Kojika, S., Abe, M., Kagami, K., Harama, D., Shinohara, T., Watanabe, A., Oshiro, H., Akahane, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27767-6 · Cited by 24
Christidi, E., Huang, H., & Brunham, L. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.06.002 · Cited by 26
Luo, J. D., Padhi, P., Jin, H., Anantharam, V., Zenitsky, G. D., Wang, Q., Willette, A. A., Kanthasamy, A., & Kanthasamy, A. G. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09844-3 · Cited by 27
“Moreover, by establishing the relationship between a mutation’s incorporation rate after DSB repair and its distance to the DSB, they generated heterozygous and homozygous dominant mutations in APP and presenilin-1 in predictable frequencies (Paquet et al. 2016).”
Genome Editing in Neurosciences
Jaenisch, R., Gage, F. H., & Zhang, F. (2017) · Research and perspectives in neurosciences · doi:10.1007/978-3-319-60192-2 · Cited by 24
Zhuo, C., Hou, W., Hu, L., Lin, C., Chen, C., & Lin, X. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00028 · Cited by 27
“…anemia and Alzheimer’s disease have been treated with the CRISPR/Cas9 technique by correcting the causative mutations and reverting the defect to the original form in the genomic DNA, and functional restoration has been gained (Huang et al., 2015; Sankaran and Weiss, 2015; Paquet et al., 2016).”
BackgroundJubair, L., & McMillan, N. A. J. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.006 · Cited by 25
“To date, several hundred publications have demonstrated the high efficiency of Cas9 endonucleases to achieve gene knockouts.(80,81) However, inserting a precise modification via the HDR repair pathway seems less efficient in most cases.”
BackgroundMethodInfluentialRoyba, E., Miyamoto, T., Akutsu, S. N., Hosoba, K., Tauchi, H., Kudo, Y., Tashiro, S., Yamamoto, T., & Matsuura, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-06393-8 · Cited by 27
Efficient SSA ‐mediated precise genome editing using CRISPR /Cas9
Li, X., Bai, Y., Cheng, X., Kalds, P., Sun, B., Wu, Y., Lv, H., Xu, K., & Zhang, Z. (2018) · FEBS Journal · doi:10.1111/febs.14626 · Cited by 26
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle, C. F., & MacLaren, R. E. (2017) · PubMed Central · Cited by 33
Du, J., Shang, J., Chen, F., Zhang, Y., Yin, N., Xie, T., Zhang, H., Yu, J., & Liu, F. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0090 · Cited by 23
“Indeed, Cas9-induced DSBs have an eventual tendency toward NHEJ repair, because if a given DSB is repaired by HR, the locus will be continuously recut by Cas9 nuclease until the protospacer adjacent motif or sgRNAbinding sequences are disrupted through NHEJ repair (45).”
BackgroundEfficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes
Huang, B., Johansen, K. H., & Schwartzberg, P. L. (2018) · Current Protocols in Immunology · doi:10.1002/cpim.62 · Cited by 26
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
Schober, K., Müller, T. R., & Busch, D. H. (2020) · Cells · doi:10.3390/cells9061367 · Cited by 25
“There is convincing evidence that the distance between the cutting site and the insert should be as small as possible [93], but it is unclear whether cutting sites that are directly in frame are disproportionately superior to short-distance cutting sites, or whether up- and downstream distances have a similar impact o…”
BackgroundBennett, H. J., Aguilar-Martínez, E., & Adamson, A. D. (2020) · Methods · doi:10.1016/j.ymeth.2020.10.012 · Cited by 22
Leptin gene-targeted editing in ob/ob mouse adipose tissue based on the CRISPR/Cas9 system
Zhu, L., Yang, X., Li, J., Jia, X., Bai, X., Zhao, Y., Cheng, W., Shu, M., Zhu, Y., & Jin, S. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.01.008 · Cited by 24
From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods
Bazaz, M. R., & Dehghani, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120409 · Cited by 27
Zhao, Z., Shang, P., Sage, F., & Geijsen, N. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac118 · Cited by 25
“Previous reports have demonstrated that mutation disrupting the PAM sequence or seed region can avoid ‘re-cutting’ of the edited genome and increase editing efficiency (36,37).”
Zhou, W., Yang, J., Zhang, Y., Hu, X., & Wang, W. (2022) · MedComm · doi:10.1002/mco2.155 · Cited by 31
Zhang, Z., Zeng, W., Zhang, W., Li, J., Kong, D., Zhang, L., Wang, R., Peng, F., Kong, Z., Ke, Y., et al. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac431 · Cited by 23
Nasrallah, A., Sulpice, E., Kobaisi, F., Gidrol, X., & Rachidi, W. (2022) · Cells · doi:10.3390/cells11223615 · Cited by 27
SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
López‐Oreja, I., Gohr, A., Playà-Albinyana, H., Giró, A., Arenas, F., Higashi, M., Tripathi, R., López‐Guerra, M., Irimia, M., Aymerich, M., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202301955 · Cited by 25
“In addition, we introduced a silent mutation replacing XGG PAM sequence by XGA (c.2106G>A), to prevent its further recognition after initial editing (Paquet et al, 2016) (Fig 1A).”
MethodPhage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
Qi, T., Wang, Y., Yang, Y., Gao, S., Liu, J., Huang, Q., Tian, Y., Tang, J., Zheng, W., & Wang, Y. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01481-5 · Cited by 23
“Precise Cas9 positioning is often required for many applications, such as base editing 9,10 , prime editing 11 and site-specific DNA recombination 12 .”
Ghatak, S., Diedrich, J. K., Talantova, M. V., Bhadra, N., Scott, H. R., Sharma, M., Albertolle, M. E., Schork, N. J., Yates, J. R., & Lipton, S. A. (2024) · Advanced Science · doi:10.1002/advs.202400545 · Cited by 24
Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease
Lau, C., & Suh, Y. (2016) · Gerontology · doi:10.1159/000452972 · Cited by 25
Applications of the CRISPR-Cas9 system in kidney research
Higashijima, Y., Hirano, S., Nangaku, M., & Nureki, O. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.037 · Cited by 25
Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer’s Disease?
Raikwar, S. P., Bhagavan, S., Ramaswamy, S. B., Thangavel, R., Dubova, I., Selvakumar, G. P., Ahmed, M. E., Kempuraj, D., Zaheer, S. A., Iyer, S. S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1123-8 · Cited by 25
Applications of CRISPR-Cas in Bioengineering, Biotechnology, and Translational Research
Lau, C. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0026 · Cited by 24
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations
Brabetz, O., Alla, V., Angenendt, L., Schliemann, C., Berdel, W. E., Arteaga, M. F., & Mikesch, J. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.012 · Cited by 23
Carvalho, C., Lemos, L., Antas, P., & Seabra, M. C. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1270561 · Cited by 21
Jeon, S., Sohn, Y. J., Lee, H., Park, J. Y., Kim, D., Lee, E. S., & Park, S. J. (2025) · The Journal of Microbiology · doi:10.71150/jm.2501021 · Cited by 22
“…directs Cas9 to its specific target site, enabling precise genomic alterations with broad applications in metabolic engineering and synthetic biology (Chen et al., 2017; Hsu et al., 2014; Huang et al., 2016; Paquet et al., 2016; Richardson et al., 2016; Shalem et al., 2014; Zerbini et al., 2017).”
CNS disease models with human pluripotent stem cells in the CRISPR age
Muffat, J., Li, Y., & Jaenisch, R. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.10.001 · Cited by 18
Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
Calatayud, C., Carola, G., Consiglio, A., & Raya, Á. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.06.002 · Cited by 22
Genetically engineered birds; pre-CRISPR and CRISPR era
Dehdilani, N., Taemeh, S. Y., Goshayeshi, L., & Dehghani, H. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab196 · Cited by 36
Lu, Y., Mbakam, C. H., Song, B., Bendavid, E., & Tremblay, J. P. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892769 · Cited by 24
“, 2018), off-target mutation (Vakulskas and Behlke, 2019) and complex undesired products (Paquet et al., 2016).”
BackgroundMSL2 ensures biallelic gene expression in mammals
Sun, Y., Wiese, M., Hmadi, R., Karayol, R., Seyfferth, J., Greene, J. A. M., Erdogdu, N. U., Deboutte, W., Arrigoni, L., Holz, H., et al. (2023) · Nature · doi:10.1038/s41586-023-06781-3 · Cited by 23
İnak, E., Rouck, S. D., Demirci, B., Dermauw, W., Geibel, S., & Leeuwen, T. V. (2024) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2024.104127 · Cited by 22
Mapping a diversity of genetic interactions in yeast
van Leeuwen, J. S., Boone, C. M., & Andrews, B. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.08.002 · Cited by 27
Thys, A., Douanne, T., & Bidère, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00498 · Cited by 27
Exploiting rare driver mutations for precision cancer medicine
Scholl, C., & Fröhling, S. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.02.004 · Cited by 25
Expanding the CRISPR/Cas9 Toolbox for Gene Engineering in S. cerevisiae
Levi, O., & Arava, Y. (2020) · Current Microbiology · doi:10.1007/s00284-019-01851-0 · Cited by 21
Aulicino, F., Capin, J., & Berger, I. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080759 · Cited by 21
“Although the NHEJ pathway is referred to as an “error-prone” DNA repair pathway, most of the Cas9-induced DSBs are presumably repaired seamlessly [31], restoring protospacer and PAM sequence creating a loop sequence of DSB induction and repair cycles.”
BackgroundEfficient genome editing of differentiated renal epithelial cells
Hofherr, A., Busch, T., Huber, N., Nold, A., Bohn, A., Viau, A., Bienaimé, F., Kuehn, E. W., Arnold, S. J., & Köttgen, M. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1924-4 · Cited by 21
“Therefore, although their sequence specificity has been shown to be fairly high—especially in comparison to RNAi—experimental designs based on TALEN or CRISPR constructs have to control for putative off-target effects [16, 19].”
Yashooa, R. K., Nabi, A. Q., Smail, S. W., Azeez, S. S., Nooh, W. A., Mustafa, S. A., Al-Farha, A. A.-B., Capitanio, N., & Shekha, M. S. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1737468 · Cited by 25
Modeling cell-cell interactions in the brain using cerebral organoids
Oliveira, B., Yahya, A. Ç., & Novarino, G. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146458 · Cited by 22
Miki, D., Wang, R., Li, J., Kong, D., Zhang, L., & Zhu, J. (2021) · Plant and Cell Physiology · doi:10.1093/pcp/pcab034 · Cited by 21
Kaserman, J. E., Werder, R. B., Wang, F., Matte, T. M., Higgins, M. I., Dodge, M., Lindstrom-Vautrin, J., Bawa, P., Hinds, A., Bullitt, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111775 · Cited by 25
“To correct one or both alleles, we introduced either one or two ssODN donors containing the Z or wild-type (M) sequence (Figure 1A).(26) Utilizing this approach, we successfully targeted 3 genetically distinct ZZ iPSC lines (referred to as PiZZ1, PiZZ6, and PiZZ100), generating 3 syngeneic sets of ZAAT homozygous (ZZ)…”
MethodASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs
Ludwik, K. A., Telugu, N. S., Schommer, S., Stachelscheid, H., & Diecke, S. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102406 · Cited by 21
“To increase a chance of obtaining heterozygous KI select the gRNAs 10bp upstream or downstream of SNP position.(8)”
BackgroundApplications of CRISPR genome editing technology in drug target identification and validation
Lu, Q., Livi, G. P., Modha, S. S., Yusa, K., Macarrón, R., & Dow, D. J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1317244 · Cited by 28
Potential Value of Genomic Copy Number Variations in Schizophrenia
Zhuo, C., Hou, W., Lin, C., Hu, L., & Li, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00204 · Cited by 24
“…the genomic DNA, including deletions or insertions in cells, plants, and entire animal models (Xiao et al., 2013; Hsu et al., 2014; Sander and Joung, 2014; Huang et al., 2015; Liang et al., 2015; Callaway, 2016; Long et al., 2016; Nelson et al., 2016; Paquet et al., 2016; Tabebordbar et al., 2016).”
BackgroundHart, J. C., & Miller, C. T. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.1125 · Cited by 22
“Injectionofevena singlegRNAis sufficient to induce large (.25 bp) deletions around the genomic target, similar in size to zebrafish reports, but larger than in human cells (Hwang et al. 2013; Paquet et al. 2016).”
BackgroundWilliams, L. A., Joshi, V., Murphy, M., Ferrante, J., Werley, C. A., Brookings, T., McManus, O. B., Grosse, J., Davies, C. H., & Dempsey, G. T. (2019) · Neurochemical Research · doi:10.1007/s11064-018-2694-5 · Cited by 22
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.